Paclitaxel Plus Ifosfamide Followed by High-Dose Carboplatin Plus Etoposide for Patients With Relapsed Primary Mediastinal Nonseminomatous Germ Cell Tumors: Benefit From Chemotherapy, Surgery, or Both?

被引：3
|
作者：
Einhorn, Lawrence H. [1 ,2 ]
Abonour, Rafat [1 ]
Kesler, Kenneth A.
机构：
[1] Melvin & Bren Simon Canc Ctr, Indianapolis, IN USA
[2] Indiana Univ Sch Med, Lance Armstrong Fdn Chair Oncol, Indianapolis, IN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 35期
关键词：
EXPERIENCE; POSTCHEMOTHERAPY;
D O I：
10.1200/JCO.2010.30.4626
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E739 / E739
页数：1
相关论文
共 50 条
  • [1] Paclitaxel Plus Ifosfamide Followed by High-Dose Carboplatin Plus Etoposide for Patients With Relapsed Primary Mediastinal Nonseminomatous Germ Cell Tumors: Benefit From Chemotherapy, Surgery, or Both? Reply
    Feldman, Darren R.
    Bosl, George J.
    Bains, Manjit
    Motzer, Robert J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (35) : E740 - E740
  • [2] Paclitaxel plus ifosfamide followed by high-dose carboplatin plus etoposide in previously treated germ cell tumors
    Kondagunta, G. Varuni
    Bacik, Jennifer
    Sheinfeld, Joel
    Bajorin, Dean
    Bains, Manjit
    Reich, Lillian
    Deluca, John
    Budnick, Amy
    Ishill, Nicole
    Mazumdar, Madhu
    Bosl, George J.
    Motzer, Robert J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (01) : 85 - 90
  • [3] Paclitaxel plus ifosfamide followed by high-dose carboplatin plus etoposide in previously treated germ cell tumors (vol 25, pg 85, 2007)
    Kondagunta
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (15) : 2149 - 2149
  • [4] Salvage treatment with paclitaxel, ifosfamide, and cisplatin plus high-dose carboplatin, etoposide, and thiotepa followed by autologous stem-cell rescue in patients with relapsed or refractory germ cell cancer
    Rick, O
    Bokemeyer, C
    Beyer, J
    Hartmann, JT
    Schwella, N
    Kingreen, D
    Neureither, S
    Metzner, B
    Casper, J
    Wandt, H
    Hartmann, F
    Schmoll, HJ
    Derigs, G
    Gerl, A
    Berdel, WE
    Kanz, L
    Siegert, W
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (01) : 81 - 88
  • [5] Phase I/II Study of Paclitaxel Plus Ifosfamide Followed By High-Dose Paclitaxel, Ifosfamide, and Carboplatin with Autologous Stem Cell Reinfusion for Salvage Treatment of Germ Cell Tumors
    Feldman, Darren R.
    Glezerman, Ilya
    Patil, Sujata
    Van Alstine, Lindsay
    Bajorin, Dean F.
    Fischer, Patricia
    Hughes, Amanda
    Sheinfeld, Joel
    Bains, Manjit
    Reich, Lilian
    Bosl, George J.
    Giralt, Sergio A.
    Motzer, Robert J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (02) : S90 - S90
  • [6] Salvage high-dose chemotherapy (HDCT) for relapsed primary mediastinal nonseminomatous germ-cell tumors (PMNSGCT).
    Taza, Fadi
    Abonour, Rafat
    Althouse, Sandra K.
    Ashkar, Ryan
    Abu Zaid, Mohammad Issam
    Hanna, Nasser H.
    Kessler, Kenneth A.
    Adra, Nabil
    Einhorn, Lawrence H.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [7] Consolidation high-dose chemotherapy for patients with primary mediastinal nonseminomatous germ cell tumor
    Banna, G. L.
    De Giorgi, U.
    Ferrari, B.
    Castagna, L.
    Alloisio, M.
    Marangolo, M.
    Rosti, G.
    Santoro, A.
    ANNALS OF ONCOLOGY, 2006, 17 : XI75 - XI75
  • [8] MEDIASTINAL NONSEMINOMATOUS GERM-CELL TUMORS - EFFECTIVENESS OF PLATINUM, ETOPOSIDE, BLEOMYCIN COMBINATION CHEMOTHERAPY PLUS ADJUNCTIVE SURGERY
    BERRUTI, A
    BORASIO, P
    PAZE, E
    MOSSETTI, C
    GORZEGNO, G
    DOGLIOTTI, L
    EUROPEAN JOURNAL OF CANCER, 1992, 28A (10) : 1773 - 1773
  • [9] SALVAGE CHEMOTHERAPY IN REFRACTORY GERM-CELL TUMORS WITH ETOPOSIDE (VP-16) PLUS IFOSFAMIDE PLUS HIGH-DOSE CISPLATIN - A VIHP REGIMEN
    GHOSN, M
    DROZ, JP
    THEODORE, C
    PICO, JL
    BAUME, D
    SPIELMANN, M
    OSTRONOFF, M
    MORAN, A
    SALLOUM, E
    KRAMAR, A
    HAYAT, M
    CANCER, 1988, 62 (01) : 24 - 27
  • [10] HIGH-DOSE CARBOPLATIN AND ETOPOSIDE FOR SALVAGE CHEMOTHERAPY OF GERM-CELL TUMORS
    LAMPE, H
    DEARNALEY, DP
    PRICE, A
    MEHTA, J
    POWLES, R
    NICHOLLS, J
    HORWICH, A
    EUROPEAN JOURNAL OF CANCER, 1995, 31A (05) : 717 - 723
12345